Follow
Dr. Ruchi Tandon
Dr. Ruchi Tandon
Scientist
Verified email at thsti.res.in
Title
Cited by
Cited by
Year
A review on leukotrienes and their receptors with reference to asthma
RK Singh, R Tandon, SG Dastidar, A Ray
Journal of Asthma 50 (9), 922-931, 2013
1282013
Hemoglobin endocytosis in Leishmania is mediated through a 46-kDa protein located in the flagellar pocket
S Sengupta, J Tripathi, R Tandon, M Raje, RP Roy, SK Basu, ...
Journal of Biological Chemistry 274 (5), 2758-2765, 1999
831999
Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action
Y Deng, S Bhattacharya, OR Swamy, R Tandon, Y Wang, R Janda, ...
Journal of Biological Chemistry 278 (41), 39311-39322, 2003
782003
Rab5-mediated endosome–endosome fusion regulates hemoglobin endocytosis in Leishmania donovani
SB Singh, R Tandon, G Krishnamurthy, R Vikram, N Sharma, SK Basu, ...
The EMBO Journal 22 (21), 5712-5722, 2003
652003
Cinnamic acid, from the bark of Cinnamomum cassia, regulates glucose transport via activation of GLUT4 on L6 myotubes in a phosphatidylinositol 3‐kinase …
BS Lakshmi, S Sujatha, S Anand, KN Sangeetha, RB Narayanan, ...
Journal of diabetes 1 (2), 99-106, 2009
562009
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment
R Tandon, S Kapoor, S Vali, V Senthil, D Nithya, R Venkataramanan, ...
European journal of pharmacology 667 (1-3), 56-65, 2011
362011
Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema?
S Mittra, G Sangle, R Tandon, S Sharma, S Roy, V Khanna, A Gupta, ...
British journal of pharmacology 150 (4), 480-487, 2007
362007
Enhanced expression of recombinant proteins utilizing a modified baculovirus expression vector
P Tiwari, S Saini, S Upmanyu, B Benjamin, R Tandon, KS Saini, S Sahdev
Molecular biotechnology 46 (1), 80-89, 2010
212010
Essential role of PSM/SH2‐B variants in insulin receptor catalytic activation and the resulting cellular responses
M Zhang, Y Deng, R Tandon, C Bai, H Riedel
Journal of cellular biochemistry 103 (1), 162-181, 2008
212008
Immunomodulation by opioid peptidomimetic compound
P Narayan, VK Singh, SS Agarwal, R Tandon, W Haq, R Raghubir, ...
Neuroimmunomodulation 9 (3), 134-140, 2001
202001
Progress in the development of small molecule inhibitors of insulin-like growth factor-1 receptor kinase
PKS Sarma, R Tandon, P Gupta, SG Dastidar, A Ray, B Das, IA Cliffe
Expert Opinion on Therapeutic Patents 17 (1), 25-35, 2007
132007
Inhibition of antigen specific lymphocyte proliferation and cytokine stimulation by peptidomimetic opioid compound
P Narayan, R Tandon, W Haq, MM Dhar, VK Singh
International immunopharmacology 2 (6), 751-757, 2002
82002
RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy
R Tandon, V Senthil, D Nithya, V Pamidiboina, A Kumar, S Malik, T Chaira, ...
European journal of pharmacology 711 (1-3), 19-26, 2013
72013
Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice
R Tandon, A Soni, RK Singh, R Sodhi, MK Seth, S Sinha, S Sahdev, ...
European Journal of Pharmacology 886, 173391, 2020
52020
Mechanism of action of Anti-diabetic property of Cinnamic acid, a principal active ingredient from the bark of Cinnamomum cassia
R Tandon, A Gupta, A Ray
International Journal of Therapeutic Applications 9, 39-45, 2013
42013
Inhibition of anti-CD3 and interleukin-2 stimulated T lymphocyte proliferation by peptidomimetic opioid compound
P Narayan, R Pandey, VS Yadav, R Tandon, W Haq, MM Dhar, VK Singh
Immunopharmacology and immunotoxicology 25 (2), 225-233, 2003
32003
Synthesis of novel tetrapeptides as potential ACE inhibitors
R Tandon, MP Singh, W Haq, M Dikshit, GK Patnaik, MM Dhar
NISCAIR-CSIR, India, 1997
21997
Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma.
SA Visaga, H Kalonia, V Verma, S Sinha, SK Singh, S Upadhyay, ...
bioRxiv, 2021
2021
Design, synthesis, and SAR of 2-acetamido-3-pyrrolidinepropanamide derivatives as urotensin-II receptor antagonists
A Soni, A Agarwal, S Saha, M Das, K Shripati, S Aeron, B Das, I Cliffe, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015
2015
Dual EGFR/IGFR inhibitor: A novel approach to overcome resistance
P Gupta, J Dullu, Y Khaimar, P Saha, R Kumar, A Siddiqui, R Tandon, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20